Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 211

1.

Routine Adoption of Urinary [IGFBP7]∙[TIMP-2] to Assess Acute Kidney Injury at Any Stage 12 hours After Intensive Care Unit Admission: a Prospective Cohort Study.

Ferrari F, Romero-González G, Topete LR, Senzolo M, Lorenzin A, Husain-Syed F, Puci MV, Ferraro OE, Muraro E, Serrano-Soto M, Triviño AM, Castro AC, Xie Y, Yang B, De Cal M, Corradi V, Brendolan A, Scarpa M, Carta MR, Giavarina D, Bonato R, Ronco C.

Sci Rep. 2019 Nov 11;9(1):16484. doi: 10.1038/s41598-019-52790-6.

2.

Development and validation of quick Acute Kidney Injury-score (q-AKI) to predict acute kidney injury at admission to a multidisciplinary intensive care unit.

Ferrari F, Puci MV, Ferraro OE, Romero-González G, Husain-Syed F, Rizo-Topete L, Senzolo M, Lorenzin A, Muraro E, Baracca A, Serrano-Soto M, Molano Triviño A, Coutinho Castro A, De Cal M, Corradi V, Brendolan A, Scarpa M, Carta MR, Giavarina D, Bonato R, Iotti GA, Ronco C.

PLoS One. 2019 Jun 20;14(6):e0217424. doi: 10.1371/journal.pone.0217424. eCollection 2019.

3.

Therapeutic Regeneration of Lymphatic and Immune Cell Functions upon Lympho-organoid Transplantation.

Lenti E, Bianchessi S, Proulx ST, Palano MT, Genovese L, Raccosta L, Spinelli A, Drago D, Andolfo A, Alfano M, Petrova TV, Mukenge S, Russo V, Brendolan A.

Stem Cell Reports. 2019 Jun 11;12(6):1260-1268. doi: 10.1016/j.stemcr.2019.04.021. Epub 2019 May 30.

4.

Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein-7 (IGFBP7) levels are associated with adverse outcomes in patients in the intensive care unit with acute kidney injury.

Xie Y, Ankawi G, Yang B, Garzotto F, Passannante A, Breglia A, Digvijay K, Ferrari F, Brendolan A, Raffaele B, Giavarina D, Gregori D, Ronco C.

Kidney Int. 2019 Jun;95(6):1486-1493. doi: 10.1016/j.kint.2019.01.020. Epub 2019 Mar 9.

PMID:
30982674
5.

Impaired testicular signaling of vitamin A and vitamin K contributes to the aberrant composition of the extracellular matrix in idiopathic germ cell aplasia.

Alfano M, Pederzoli F, Locatelli I, Ippolito S, Longhi E, Zerbi P, Ferrari M, Brendolan A, Montorsi F, Drago D, Andolfo A, Nebuloni M, Salonia A.

Fertil Steril. 2019 Apr;111(4):687-698. doi: 10.1016/j.fertnstert.2018.12.002.

6.

ACUsmart Continuous Renal Replacement Therapy Platform: Multicenter Pilot Study for Technical and Clinical Assessment (A.M.P. Study).

Neri M, Lorenzin A, de Cal M, Brendolan A, Marchionna N, Samoni S, Zanella M, De Rosa S, Martino F, Ricci Z, Maynar J, Auzinger G, Villa G, Payen D, Joannidis M, Ronco C.

Blood Purif. 2019;48(1):60-66. doi: 10.1159/000496090. Epub 2019 Feb 1.

7.

Direct Effect of Septic Plasma in Human Cell Lines Viability.

Virzì GM, Borga C, Pasqualin C, Pastori S, Brocca A, de Cal M, Nalesso F, Zanella M, Brendolan A, Ronco C.

Blood Purif. 2019;47(1-3):270-276. doi: 10.1159/000494597. Epub 2018 Dec 6.

8.

Presepsin and Procalcitonin Levels as Markers of Adverse Postoperative Complications and Mortality in Cardiac Surgery Patients.

Clementi A, Virzì GM, Muciño-Bermejo MJ, Nalesso F, Giavarina D, Carta M, Brocca A, de Cal M, Hinna Danesi T, Zanella M, Marchionna N, Brendolan A, Battaglia GG, Salvador L, Ronco C.

Blood Purif. 2019;47(1-3):140-148. doi: 10.1159/000494207. Epub 2018 Oct 18.

PMID:
30336490
9.

Expanded haemodialysis: from operational mechanism to clinical results.

Ronco C, Marchionna N, Brendolan A, Neri M, Lorenzin A, Martínez Rueda AJ.

Nephrol Dial Transplant. 2018 Oct 1;33(suppl_3):iii41-iii47. doi: 10.1093/ndt/gfy202. Review.

10.

Persistent decrease of renal functional reserve in patients after cardiac surgery-associated acute kidney injury despite clinical recovery.

Husain-Syed F, Ferrari F, Sharma A, Hinna Danesi T, Bezerra P, Lopez-Giacoman S, Samoni S, de Cal M, Corradi V, Virzì GM, De Rosa S, Muciño Bermejo MJ, Estremadoyro C, Villa G, Zaragoza JJ, Caprara C, Brocca A, Birk HW, Walmrath HD, Seeger W, Nalesso F, Zanella M, Brendolan A, Giavarina D, Salvador L, Bellomo R, Rosner MH, Kellum JA, Ronco C.

Nephrol Dial Transplant. 2019 Feb 1;34(2):308-317. doi: 10.1093/ndt/gfy227.

PMID:
30053231
11.

Quantification of Internal Filtration in Hollow Fiber Hemodialyzers with Medium Cut-Off Membrane.

Lorenzin A, Neri M, Lupi A, Todesco M, Santimaria M, Alghisi A, Brendolan A, Ronco C.

Blood Purif. 2018;46(3):196-204. doi: 10.1159/000489993. Epub 2018 Jun 8.

12.

A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression.

Farinello D, Wozińska M, Lenti E, Genovese L, Bianchessi S, Migliori E, Sacchetti N, di Lillo A, Bertilaccio MTS, de Lalla C, Valsecchi R, Gleave SB, Lligé D, Scielzo C, Mauri L, Ciampa MG, Scarfò L, Bernardi R, Lazarevic D, Gonzalez-Farre B, Bongiovanni L, Campo E, Cerutti A, Ponzoni M, Pattini L, Caligaris-Cappio F, Ghia P, Brendolan A.

Nat Commun. 2018 May 3;9(1):1787. doi: 10.1038/s41467-018-04150-7.

13.

Discontinuation of Continuous Renal Replacement Therapy and Dialysis Dependence.

Romero-González G, Lorenzin A, Neri M, Ferrari F, Molano-Triviño A, Brendolan A, Ronco C.

Contrib Nephrol. 2018;194:118-125. doi: 10.1159/000485609. Epub 2018 Mar 29. Review.

PMID:
29597223
14.

Origin and Immunological Functions of Spleen Stromal Cells.

Golub R, Tan J, Watanabe T, Brendolan A.

Trends Immunol. 2018 Jun;39(6):503-514. doi: 10.1016/j.it.2018.02.007. Epub 2018 Mar 19. Review.

PMID:
29567327
15.

Fistula Cannulation with a Novel Fistula Cannula: A Review of Cannulation Devices and Procedures.

Nalesso F, Garzotto F, Muraro E, Brendolan A, Ronco C.

Blood Purif. 2018;45(1-3):278-283. doi: 10.1159/000485594. Epub 2018 Jan 26. Review.

16.

Predicting Acute Kidney Injury in Intensive Care Unit Patients: The Role of Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor-Binding Protein-7 Biomarkers.

Di Leo L, Nalesso F, Garzotto F, Xie Y, Yang B, Virzì GM, Passannante A, Bonato R, Carta M, Giavarina D, Gregori D, Brendolan A, Ferrari F, Ronco C.

Blood Purif. 2018;45(1-3):270-277. doi: 10.1159/000485591. Epub 2018 Jan 26.

17.

Preoperative Renal Functional Reserve Predicts Risk of Acute Kidney Injury After Cardiac Operation.

Husain-Syed F, Ferrari F, Sharma A, Danesi TH, Bezerra P, Lopez-Giacoman S, Samoni S, de Cal M, Corradi V, Virzì GM, De Rosa S, Muciño Bermejo MJ, Estremadoyro C, Villa G, Zaragoza JJ, Caprara C, Brocca A, Birk HW, Walmrath HD, Seeger W, Nalesso F, Zanella M, Brendolan A, Giavarina D, Salvador L, Bellomo R, Rosner MH, Kellum JA, Ronco C.

Ann Thorac Surg. 2018 Apr;105(4):1094-1101. doi: 10.1016/j.athoracsur.2017.12.034. Epub 2018 Jan 31.

PMID:
29382510
18.

The E3 ubiquitin ligase WWP1 sustains the growth of acute myeloid leukaemia.

Sanarico AG, Ronchini C, Croce A, Memmi EM, Cammarata UA, De Antoni A, Lavorgna S, Divona M, Giacò L, Melloni GEM, Brendolan A, Simonetti G, Martinelli G, Mancuso P, Bertolini F, Coco FL, Melino G, Pelicci PG, Bernassola F.

Leukemia. 2018 Apr;32(4):911-919. doi: 10.1038/leu.2017.342. Epub 2017 Dec 6.

19.

Hemodialysis versus peritoneal dialysis: an observational study in two international centers.

Lu R, Estremadoyro C, Chen X, Zhu M, Ribeiro LC, Yan Y, Brendolan A, Fang W, Crepaldi C, Ni Z, Gu L, Ronco C.

Int J Artif Organs. 2017 Nov 8:0. doi: 10.5301/ijao.5000656. [Epub ahead of print]

PMID:
29148022
20.

Routine adoption of TIMP2 and IGFBP7 biomarkers in cardiac surgery for early identification of acute kidney injury.

Levante C, Ferrari F, Manenti C, Husain-Syed F, Scarpa M, Hinna Danesi T, De Cal M, Corradi V, Virzì GM, Brendolan A, Nalesso F, Bezerra P, Lopez-Giacoman S, Samoni S, Senzolo M, Giavarina D, Salvador L, Bonato R, De Rosa S, Rettore E, Ronco C.

Int J Artif Organs. 2017 Nov 24;40(12):714-718. doi: 10.5301/ijao.5000661. Epub 2017 Nov 16.

21.

Modeling of Internal Filtration in Theranova Hemodialyzers.

Lorenzin A, Neri M, Clark WR, Garzotto F, Brendolan A, Nalesso F, Marchionna N, Zanella M, Sartori M, Fiore GB, Ronco C.

Contrib Nephrol. 2017;191:127-141. doi: 10.1159/000479261. Epub 2017 Sep 14.

PMID:
28910796
22.

Prospective, randomized, multicenter, controlled trial (TRIATHRON 1) on a new antithrombogenic hydrophilic dialysis membrane.

Ronco C, Brendolan A, Nalesso F, Zanella M, De Cal M, Corradi V, Virzì GM, Ferrari F, Garzotto F, Lorenzin A, Karopadi AN, Sartori M, De Rosa S, Samoni S, Husain-Syed F, Spinelli A, Neri M, Villa G, Alghisi A.

Int J Artif Organs. 2017 May 29;40(5):234-239. doi: 10.5301/ijao.5000608. [Epub ahead of print]

23.

Development of the New Kibou® Equipment for Continuous Renal Replacement Therapy from Scratch to the Final Configuration.

Neri M, Lorenzin A, Brendolan A, Garzotto F, Ferrari F, De Rosa S, Bonato R, Villa G, Bazzano S, D''Ippoliti F, Ricci Z, La Manna G, Ronco C.

Contrib Nephrol. 2017;190:58-70. doi: 10.1159/000468914. Epub 2017 May 23. Review.

PMID:
28535519
24.

Rationale for the Evaluation of Renal Functional Reserve in Living Kidney Donors and Recipients: A Pilot Study.

Spinelli A, Sharma A, Villa G, Samoni S, Ramponi F, Brocca A, Brendolan A, Chiaramonte S, Castellano G, Gesualdo L, Ronco C.

Nephron. 2017;135(4):268-276. doi: 10.1159/000454931. Epub 2017 Jan 5.

PMID:
28052302
25.

Intra-Parenchymal Renal Resistive Index Variation (IRRIV) Describes Renal Functional Reserve (RFR): Pilot Study in Healthy Volunteers.

Samoni S, Nalesso F, Meola M, Villa G, De Cal M, De Rosa S, Petrucci I, Brendolan A, Rosner MH, Ronco C.

Front Physiol. 2016 Jul 6;7:286. doi: 10.3389/fphys.2016.00286. eCollection 2016.

26.

Optimizing a kidney stress test to evaluate renal functional reserve.

Sharma A, Zaragoza JJ, Villa G, Ribeiro LC, Lu R, Sartori M, Faggiana E, de Cal M, Virzi GM, Corradi V, Brocca A, Husain-Syed F, Brendolan A, Ronco C.

Clin Nephrol. 2016 Jul;86(7):18-26. doi: 10.5414/CN108497.

PMID:
27285313
27.

Transcription factor TLX1 controls retinoic acid signaling to ensure spleen development.

Lenti E, Farinello D, Yokoyama KK, Penkov D, Castagnaro L, Lavorgna G, Wuputra K, Sandell LL, Tjaden NE, Bernassola F, Caridi N, De Antoni A, Wagner M, Kozinc K, Niederreither K, Blasi F, Pasini D, Majdic G, Tonon G, Trainor PA, Brendolan A.

J Clin Invest. 2016 Jul 1;126(7):2452-64. doi: 10.1172/JCI82956. Epub 2016 May 23.

28.

Lymphoid Tissue Mesenchymal Stromal Cells in Development and Tissue Remodeling.

Genovese L, Brendolan A.

Stem Cells Int. 2016;2016:8419104. doi: 10.1155/2016/8419104. Epub 2016 Apr 13. Review.

29.

Impact of hyperhydration on the mortality risk in critically ill patients admitted in intensive care units: comparison between bioelectrical impedance vector analysis and cumulative fluid balance recording.

Samoni S, Vigo V, Reséndiz LI, Villa G, De Rosa S, Nalesso F, Ferrari F, Meola M, Brendolan A, Malacarne P, Forfori F, Bonato R, Donadio C, Ronco C.

Crit Care. 2016 Apr 8;20:95. doi: 10.1186/s13054-016-1269-6.

30.

HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment.

Valsecchi R, Coltella N, Belloni D, Ponente M, Ten Hacken E, Scielzo C, Scarfò L, Bertilaccio MT, Brambilla P, Lenti E, Martinelli Boneschi F, Brendolan A, Ferrero E, Ferrarini M, Ghia P, Tonon G, Ponzoni M, Caligaris-Cappio F, Bernardi R.

Blood. 2016 Apr 21;127(16):1987-97. doi: 10.1182/blood-2015-07-657056. Epub 2016 Jan 29.

31.

Con-Current versus Counter-Current Dialysate Flow during CVVHD. A Comparative Study for Creatinine and Urea Removal.

Baldwin I, Baldwin M, Fealy N, Neri M, Garzotto F, Kim JC, Giuliani A, Basso F, Nalesso F, Brendolan A, Ronco C.

Blood Purif. 2016;41(1-3):171-6. doi: 10.1159/000441270. Epub 2016 Jan 15.

32.

In vitro Cytotoxicity of Bisphenol A in Monocytes Cell Line.

Neri M, Virzì GM, Brocca A, Garzotto F, Kim JC, Ramponi F, de Cal M, Lorenzin A, Brendolan A, Nalesso F, Zanella M, Ronco C.

Blood Purif. 2015;40(2):180-6.

PMID:
26305014
33.

Peritoneal dialysis in patients with refractory congestive heart failure: a systematic review.

Lu R, Muciño-Bermejo MJ, Ribeiro LC, Tonini E, Estremadoyro C, Samoni S, Sharma A, Zaragoza Galván Jde J, Crepaldi C, Brendolan A, Ni Z, Rosner MH, Ronco C.

Cardiorenal Med. 2015 Apr;5(2):145-56. doi: 10.1159/000380915. Review.

34.

Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM).

Ronco C, Garzotto F, Brendolan A, Zanella M, Bellettato M, Vedovato S, Chiarenza F, Ricci Z, Goldstein SL.

Lancet. 2014 May 24;383(9931):1807-13. doi: 10.1016/S0140-6736(14)60799-6.

PMID:
24856026
35.

Fluid management in the intensive care unit: bioelectrical impedance vector analysis as a tool to assess hydration status and optimal fluid balance in critically ill patients.

Basso F, Berdin G, Virzì GM, Mason G, Piccinni P, Day S, Cruz DN, Wjewodzka M, Giuliani A, Brendolan A, Ronco C.

Blood Purif. 2013;36(3-4):192-9. doi: 10.1159/000356366. Epub 2013 Dec 20.

36.

Effects of fluid overload on heart rate variability in chronic kidney disease patients on hemodialysis.

Ferrario M, Moissl U, Garzotto F, Cruz DN, Clementi A, Brendolan A, Tetta C, Gatti E, Signorini MG, Cerutti S, Ronco C.

BMC Nephrol. 2014 Feb 4;15:26. doi: 10.1186/1471-2369-15-26.

37.

Comparison and Reproducibility of Techniques for Fluid Status Assessment in Chronic Hemodialysis Patients.

Basso F, Milan Manani S, Cruz DN, Teixeira C, Brendolan A, Nalesso F, Zanella M, Ronco C.

Cardiorenal Med. 2013 Jul;3(2):104-112. Epub 2013 May 15.

38.

[Timing and dose in renal replacement therapy].

Nalesso F, Giuliani A, Basso F, Brendolan A, Ronco C.

Cir Cir. 2013 May-Jun;81(3):177-80. Spanish. No abstract available.

PMID:
23769244
39.

Analysis of the DNA-binding profile and function of TALE homeoproteins reveals their specialization and specific interactions with Hox genes/proteins.

Penkov D, Mateos San Martín D, Fernandez-Díaz LC, Rosselló CA, Torroja C, Sánchez-Cabo F, Warnatz HJ, Sultan M, Yaspo ML, Gabrieli A, Tkachuk V, Brendolan A, Blasi F, Torres M.

Cell Rep. 2013 Apr 25;3(4):1321-33. doi: 10.1016/j.celrep.2013.03.029. Epub 2013 Apr 18.

40.

Nkx2-5(+)islet1(+) mesenchymal precursors generate distinct spleen stromal cell subsets and participate in restoring stromal network integrity.

Castagnaro L, Lenti E, Maruzzelli S, Spinardi L, Migliori E, Farinello D, Sitia G, Harrelson Z, Evans SM, Guidotti LG, Harvey RP, Brendolan A.

Immunity. 2013 Apr 18;38(4):782-91. doi: 10.1016/j.immuni.2012.12.005.

41.

Purity and stability of online-prepared hemodiafiltration fluid after storage.

Corradi V, Cruz D, Vázquez-Rangel A, Furlan F, Grillone R, Bonaccorsi A, Cazzavillan S, de Cal M, Frisone P, Morea A, Brendolan A, Rassu M, Ronco C.

Blood Purif. 2013;35(1-3):112-8. doi: 10.1159/000346095. Epub 2013 Jan 22.

42.

Mesenchymal cell differentiation during lymph node organogenesis.

Brendolan A, Caamaño JH.

Front Immunol. 2012 Dec 14;3:381. doi: 10.3389/fimmu.2012.00381. eCollection 2012.

43.

[Extracorporeal treatment of acute kidney injury during sepsis].

Nalesso F, Brendolan A, Zanella M, Ronco C.

G Ital Nefrol. 2012 Sep-Oct;29 Suppl 56:S35-40. Italian.

PMID:
23059938
44.

Statin therapy is associated with decreased small, dense low-density lipoprotein levels in patients undergoing peritoneal dialysis.

Clementi A, Kim JC, Floris M, Cruz DN, Garzotto F, Zanella M, Nalesso F, Brendolan A, Giavarina D, Soffiati G, Ronco C.

Contrib Nephrol. 2012;178:111-115. doi: 10.1159/000337829. Epub 2012 May 25.

PMID:
22652726
45.

Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module.

Koss M, Bolze A, Brendolan A, Saggese M, Capellini TD, Bojilova E, Boisson B, Prall OW, Elliott DA, Solloway M, Lenti E, Hidaka C, Chang CP, Mahlaoui N, Harvey RP, Casanova JL, Selleri L.

Dev Cell. 2012 May 15;22(5):913-26. doi: 10.1016/j.devcel.2012.02.009. Epub 2012 May 3.

46.

Evaluation of a new polysulfone hemofilter for continuous renal replacement therapy.

Floris M, Marchionna N, Clementi A, Kim JC, Cruz DN, Nalesso F, Zanella M, Garzotto F, de Cal M, Virzì GM, Brendolan A, Ronco C.

Blood Purif. 2011;32(2):133-8. doi: 10.1159/000325221. Epub 2011 Jun 7.

PMID:
21654165
47.

Body composition and heart rate variability to achieve dry weight and tolerance.

Nalesso F, Ferrario M, Moissl U, Brendolan A, Zanella M, Cruz DN, Basso F, Floris M, Clementi A, Garzotto F, Tetta C, Signorini MG, Cerrutti S, Ronco C.

Contrib Nephrol. 2011;171:181-186. doi: 10.1159/000327334. Epub 2011 May 23. Review.

PMID:
21625109
48.

Antioxidant dialytic approach with vitamin E-coated membranes.

Panagiotou A, Nalesso F, Zanella M, Brendolan A, de Cal M, Cruz D, Basso F, Floris M, Clementi A, Ronco C.

Contrib Nephrol. 2011;171:101-106. doi: 10.1159/000327204. Epub 2011 May 23. Review.

PMID:
21625097
49.

An innovative technology for safe needle disconnection after hemodialysis.

Lentini P, de Cal M, Chronopoulos A, Cruz D, Nalesso F, Garzotto F, Brendolan A, D'Angelo A, Ronco C.

J Vasc Access. 2011 Jul-Sep;12(3):239-43. doi: 10.5301/JVA.2011.6224.

PMID:
21279946
50.

The role of advanced oxidation protein products in intensive care unit patients with acute kidney injury.

Lentini P, de Cal M, Cruz D, Chronopoulos A, Soni S, Nalesso F, Zanella M, Garzotto F, Brendolan A, Piccinni P, Ronco C.

J Crit Care. 2010 Dec;25(4):605-9. doi: 10.1016/j.jcrc.2010.04.006.

PMID:
20537505

Supplemental Content

Loading ...
Support Center